Free Trial
→ Your book is inside (From Profits Run) (Ad)tc pixel Free ESLAW Stock Alerts

Estrella Immunopharma (ESLAW) Competitors

Estrella Immunopharma logo
$0.12 0.00 (-1.09%)
As of 06/5/2026 09:30 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

ESLAW vs. SXTPW, DRTSW, APLMW, BIVIW, and CDIOW

Should you buy Estrella Immunopharma stock or one of its competitors? MarketBeat compares Estrella Immunopharma with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Estrella Immunopharma include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). These companies are all part of the "biotechnology" industry.

How does Estrella Immunopharma compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Estrella Immunopharma (NASDAQ:ESLAW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability.

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than Estrella Immunopharma. MarketBeat recorded 1 mentions for 60 Degrees Pharmaceuticals and 0 mentions for Estrella Immunopharma. 60 Degrees Pharmaceuticals' average media sentiment score of 0.00 equaled Estrella Immunopharma'saverage media sentiment score.

Company Overall Sentiment
60 Degrees Pharmaceuticals Neutral
Estrella Immunopharma Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A
Estrella ImmunopharmaN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
Estrella Immunopharma N/A N/A N/A

Summary

60 Degrees Pharmaceuticals beats Estrella Immunopharma on 2 of the 2 factors compared between the two stocks.

How does Estrella Immunopharma compare to Alpha Tau Medical?

Estrella Immunopharma (NASDAQ:ESLAW) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Estrella ImmunopharmaN/AN/AN/AN/AN/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Estrella ImmunopharmaN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

In the previous week, Estrella Immunopharma's average media sentiment score of 0.00 equaled Alpha Tau Medical'saverage media sentiment score.

Company Overall Sentiment
Estrella Immunopharma Neutral
Alpha Tau Medical Neutral

Summary

Estrella Immunopharma and Alpha Tau Medical tied by winning 0 of the 0 factors compared between the two stocks.

How does Estrella Immunopharma compare to Apollomics?

Estrella Immunopharma (NASDAQ:ESLAW) and Apollomics (NASDAQ:APLMW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, media sentiment, profitability and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Estrella ImmunopharmaN/AN/AN/AN/AN/A
Apollomics$8.50MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Estrella ImmunopharmaN/A N/A N/A
Apollomics N/A N/A N/A

In the previous week, Estrella Immunopharma's average media sentiment score of 0.00 equaled Apollomics'average media sentiment score.

Company Overall Sentiment
Estrella Immunopharma Neutral
Apollomics Neutral

Summary

Apollomics beats Estrella Immunopharma on 1 of the 1 factors compared between the two stocks.

How does Estrella Immunopharma compare to BioVie?

Estrella Immunopharma (NASDAQ:ESLAW) and BioVie (NASDAQ:BIVIW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, media sentiment, valuation, profitability, dividends and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Estrella ImmunopharmaN/AN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Estrella ImmunopharmaN/A N/A N/A
BioVie N/A N/A N/A

In the previous week, Estrella Immunopharma's average media sentiment score of 0.00 equaled BioVie'saverage media sentiment score.

Company Overall Sentiment
Estrella Immunopharma Neutral
BioVie Neutral

Summary

Estrella Immunopharma and BioVie tied by winning 0 of the 0 factors compared between the two stocks.

How does Estrella Immunopharma compare to Cardio Diagnostics?

Estrella Immunopharma (NASDAQ:ESLAW) and Cardio Diagnostics (NASDAQ:CDIOW) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.

Company Net Margins Return on Equity Return on Assets
Estrella ImmunopharmaN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

In the previous week, Estrella Immunopharma's average media sentiment score of 0.00 equaled Cardio Diagnostics'average media sentiment score.

Company Overall Sentiment
Estrella Immunopharma Neutral
Cardio Diagnostics Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Estrella ImmunopharmaN/AN/AN/AN/AN/A
Cardio Diagnostics$16.57KN/AN/AN/AN/A

Summary

Cardio Diagnostics beats Estrella Immunopharma on 1 of the 1 factors compared between the two stocks.

Get Estrella Immunopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for ESLAW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ESLAW vs. The Competition

Export
MetricEstrella ImmunopharmaBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$452.84M$6.47B$12.45B
Dividend YieldN/A3.87%2.67%5.34%
P/E RatioN/A3.2023.6923.63
Price / SalesN/A6,606.57521.65120.49
Price / CashN/A13.1342.3557.17
Price / BookN/A83.479.736.37
Net IncomeN/A-$96.07M$3.56B$337.36M
7 Day Performance-12.53%-1.96%-2.92%-2.39%
1 Month PerformanceN/A1.01%-0.85%-0.58%
1 Year PerformanceN/A64.65%22.23%25.53%

Estrella Immunopharma Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ESLAW
Estrella Immunopharma
N/A$0.12
-1.1%		N/A+194.3%$0.00N/AN/AN/A
SXTPW
60 Degrees Pharmaceuticals
N/A$0.04
-14.4%		N/A-23.1%$0.00$1.00MN/A2
DRTSW
Alpha Tau Medical
N/A$2.80
+17.6%		N/A+805.0%$0.00N/AN/A80
APLMW
Apollomics
N/A$0.01
+1.5%		N/A-37.6%$0.00$8.50MN/A59
BIVIW
BioVie
N/A$0.35
+12.9%		N/AN/A$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:ESLAW) was last updated on 6/6/2026 by MarketBeat.com Staff.
From Our Partners
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
SpaceX is offering you shares. Don't take them.
SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. But at...
Behind the Markets | Sponsoredtc pixel
Pre-IPO Warning: SPCX [Watch Now!]
Tech investor James Altucher - who called Netflix, Facebook, and Bitcoin early - says the SpaceX IPO (Ticker: ...
Paradigm Press | Sponsoredtc pixel
How to get into the SpaceX IPO before June 12
Former tech executive and angel investor Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before their h...
Brownstone Research | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
She called ASTS before it ran 133%. Here's the system behind it.
Danielle Shay called AST SpaceMobile on Fox Business before it ran 133% - and found NBIS at $54 before it gapp...
Simpler Trading | Sponsoredtc pixel
Why is this free?
Simple Options Trading For Beginners normally sells for $29.97 - but right now Bill Poulos has opened a free w...
Profits Run | Sponsoredtc pixel
60 of America’s largest companies are whispering it
Sixty of the S-and-P 500's largest companies are now using the same word in their legally binding 10-K SEC fil...
Porter & Company | Sponsoredtc pixel